News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dr. Reddy's Laboratories, Inc. (RDY)'s Drops Efforts on Novartis AG (NVS) Drug Clone


7/6/2012 8:06:49 AM

Dr Reddy’s Laboratories has dropped plans of developing a generic version of Novartis’ anti-fungal skin/nails treatment drug Lamifil (terbinafine hydrochloride), which has estimated sales of $1 billion in its various variants. The company is believed to have spent about Rs 25 crore on the development process so far, but with the drug indicating low levels of efficacy, it has been dumped, said sources familiar with the development. C.0

Read at DNA India


comments powered by Disqus
DNA India
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES